NCT00791778

Who might be able to join this trial:

• You have been diagnosed with advanced ovarian cancer (stage III or IV) or a related cancer called primary peritoneal cancer, confirmed by laboratory testing of tissue samples.
• After surgery to remove the tumor and 4 to 6 rounds of standard chemotherapy (using platinum and taxane-based drugs), all signs of cancer have completely disappeared on scans and tests.
• Your blood test for a cancer marker called CA125 is within the normal range, taken within 7 days before starting the study drug.
• You are generally well enough to carry out light activity and care for yourself (this is measured on a standard scale called ECOG, with a score of 0 or 1).
• Your scans confirming that the cancer is gone were done within 30 days before joining the trial.
• You are able to swallow and keep down tablets or capsules taken by mouth.

Who may not be able to join:

• Any cancer tissue is still visible on a CT or MRI scan after completing chemotherapy.
• You have previously had radiotherapy to the area, chemotherapy before surgery, or chemotherapy given directly into the abdomen.
• Your ovarian cancer is not the epithelial type — for example, if it has been identified as sarcoma, lymphoma, or germ cell cancer.
• You have had major surgery, an open biopsy, or a serious physical injury within the 30 days before joining the trial.

Important: Always verify eligibility with the trial site directly before applying.